Functionalized multiwalled carbon nanotubesanticancer drug carriers: Synthesis, targeting ability and antitumor activity

Nano Biomedicine and Engineering

Volumn 3, Issue 3, 2011, Pages 157-162

  Tian, Zhong ^a   Shi, Yinfeng ^a   Yin, Min ^a   Shen, Hebei ^a   Jia, Nengqin ^a  

^a SHANGHAI NORMAL UNIVERSITY   (China)

Author keywords

Drug delivery; Folic acid; Multiwalled carbon nanotubes; Paclitaxel; Quantum dots

Indexed keywords

EID: 80053437224     PISSN: None     EISSN: 21505578     Source Type: Journal    
DOI: 10.5101/nbe.v3i3.p157-162     Document Type: Article

References (26)

1. You J, Hu FQ, Du YZ, Yuan H. Improved cytotoxicity of doxorubicin by enhancing its nuclear delivery mediated via nanosizedmicelles. Nanotechnology 2008; 9: 255103-255111. doi:10.1088/0957-4484/19/25/255103
2. Luo Y, Ziebell MR, Prestwich GD. A hyaluronic acid-Taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules 200 0; 1: 208-218. doi:10.1021/bm000283n
3. Hood JD, Frausto R. Tumor regression by targeted gene delivery to the neovasculature. Science 2002; 296: 2404-2407. doi:10.1126/ science.1070200
4. Ran S, Downes A, Thorpe PE. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res 2002; 62: 6132-6140.
5. Park JW, et al. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin. Cancer Res 2002; 8: 1172-1181.
6. Pastorino F, Marimpietri D, Marimpietri D. Doxorubicin-loadedFab fragments of antidisialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice. Cancer Res 2003; 63: 86-92.
7. Ishida T, Kirchmeier MJ, Moase EH, Zalipsky S, Allen TM. Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. Biochim. Biophys Acta 2001; 1515: 144-158. doi:10.1016/S0005-2736(01)00409-6
8. Bhirde AA, Patel V, Gavard J, Zhang GF, Sousa AA, Masedunskas A, Leapman RD, Weigert R, Gutkind JS, Rusling JF. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 2009; 3: 307-316. doi:10. 1021/nn800551s
9. Singha R, Kim GJ. Nie S, Shin DM. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther 2006; 5: 1909-1917. doi:10.1158/1535-7163.MCT-06-0141
10. Allen T, Cullis P. Drug delivery systems: entering the mainstream. Science 2004; 303: 1818-1822. doi:10.1126/science.1095833
11. Moghimi SM, Hunter AC, Murray JC. Long-circulating and targetspecific nanoparticles: theory to practice. Pharmacol Rev 2001; 53: 283-318.
12. Chen SH, Ji YX, Lian Q, Wen YL, Shen Hb, Jia NQ. Gold nanorods coated with multilayer polyelectrolyte as intracellular delivery vector of antisense oligonucleotides. Nano Biomed Eng 2010; 2(1): 15-23
13. Ajayan PM. Nanotubes from carbon. Chem Rev 1999; 99: 1787-1800. doi:10.1021/cr970102g
14. Hersam MC. Progress towards monodisperse single-walled carbon nanotubes. Nat Nanotechnol 2008; 3: 387-394. doi:10.1038/nnano. 2008.135
15. Cui D, et al. Effects of CdSe/Zs quantum dots covered multi-walled carbon nanotubes on murine embryonic stem cells. Nano Biomed. Eng. 2010; 2(4): 236-244. doi:10.5101/nbe.v2i4.p236-244
16. Chen R, Zhang Y, Wang D, Dai H. Non-covalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization. J Am Chem Soc 2001; 123(16): 3838-3839. doi:10.1021/ja010 172b
17. Kam, NWS, Liu Z, Dai H. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc 2005; 127(36): 12492-12493. doi:10.1021/ja053962k
18. Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalised carbon nanotubes. Chem Commun 2005; 5: 571-577. doi:10.1039/b410943k
19. Kam NWS, O'Connell M, Wisdom JA, Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci 2005; 102: 116 00-11605. doi:10.1073/pnas.0502680102
20. Kam NWS, Liu Z, Dai H. Functionalization of carbon nanotubes via cleavable Disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc 2005; 127: 12492-12493. doi:10.1021/ja053962k
21. Jia NQ, Lian Q, Shen HB, Wang C, Li XY, Yang ZN. Intracellular delivery of quantum dots tagged antisense oligodeoxynucleotides by functionalized multiwalled carbon nanotubes. Nano Lett 2007; 10: 2976-2980. doi:10.1021/nl071114c
22. You J, Li X, Cui FD, Du YZ, Yuan H, Hu FQ. Folate-conjugated polymer micelles for active targeting to cancer cells: preparation, in vitro evaluation of targeting ability and cytotoxicity. Nanotechnology 2008; 19: 045102(9pp).
23. Luo Y, Ziebell MR, Prestwich GD. A hyaluronic acid-Taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules 2000; 1: 208-218. doi:10.1021/bm000283n
24. Grecory RE, Anne FD. Paclitaxel: A new antineoplastic agent for refractory ovarian cancer. Clin Pharm 1993; 12: 401-415.
25. Kamaly N, Kalber T, Thanou M, Bell JD, Miller AD. Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging. Bioconjugate Chem 2009; 20: 648-655. doi:10.1021/bc8002259
26. Sonvico F, Mornet S, Vasseur S, Dubernet C, Jaillard D, Degrouard J, et al. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators:synthesis, physicochemical characterization, and in vitro experiments. Bioconjugate Chemistry 2006; 16: 1181-1188. doi:10.1021/bc05 0050z